Skip to main content
. 2011 Jun;4(6):31–40.

Table 7.

Summary of adverse event incidence after 12 weeks of treatment: Number (%) of safety evaluable patients

PARAMETER CLIN/RA GEL
n=1008
CLINDAMYCIN GEL
n=1002
Patients with at least one AE 270 (26.8) 236 (23.6)
Total number of AEs 409 387
Patients with at least one serious AE 2 (0.2) 3 (0.3)
Patients with at least one severe AE 4 (0.4) 9 (0.9)
Patients with at least one treatment-related AE 42 (4.2) 17 (1.7)
Patients discontinued due to an AE 7 (0.7) 4 (0.4)
AE
adverse event